Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Mouse models of colon cancer.

Taketo MM, Edelmann W.

Gastroenterology. 2009 Mar;136(3):780-98. Review.

PMID:
19263594
2.

Mouse models of gastrointestinal tumors.

Taketo MM.

Cancer Sci. 2006 May;97(5):355-61. Review.

3.

Multistep carcinogenesis of the colon in Apc(Min/+) mouse.

Yamada Y, Mori H.

Cancer Sci. 2007 Jan;98(1):6-10. Review.

4.

Apc mice: models, modifiers and mutants.

McCart AE, Vickaryous NK, Silver A.

Pathol Res Pract. 2008;204(7):479-90. doi: 10.1016/j.prp.2008.03.004. Epub 2008 Jun 5. Review.

PMID:
18538487
5.

Experimental models of gene-environment interaction for cancer chemoprevention studies.

Hursting SD.

Curr Opin Oncol. 1997 Sep;9(5):487-91. Review.

PMID:
9327228
6.

Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP.

Nakagama H, Nakanishi M, Ochiai M.

Cancer Sci. 2005 Oct;96(10):627-36. Review.

7.

Spontaneous and engineered mutant mice as models for experimental and comparative pathology: history, comparison, and developmental technology.

Roths JB, Foxworth WB, McArthur MJ, Montgomery CA, Kier AB.

Lab Anim Sci. 1999 Feb;49(1):12-34. Review.

PMID:
10090091
8.

Conditional mouse models of cancer.

Vignjevic D, Fre S, Louvard D, Robine S.

Handb Exp Pharmacol. 2007;(178):263-87. Review.

PMID:
17203659
9.

The utility of genetically altered mouse models for nutrition and cancer chemoprevention research.

Hursting SD, Nunez NP, Patel AC, Perkins SN, Lubet RA, Barrett JC.

Mutat Res. 2005 Aug 25;576(1-2):80-92. Review.

PMID:
15990122
10.

Genetically altered mouse models: the good, the bad, and the ugly.

Thyagarajan T, Totey S, Danton MJ, Kulkarni AB.

Crit Rev Oral Biol Med. 2003;14(3):154-74. Review.

PMID:
12799320
11.

The promise of genetically engineered mice for cancer prevention studies.

Green JE, Hudson T.

Nat Rev Cancer. 2005 Mar;5(3):184-98. Review.

PMID:
15738982
12.

Physical activity and cancer prevention: animal-tumor models.

Hoffman-Goetz L.

Med Sci Sports Exerc. 2003 Nov;35(11):1828-33. Review.

PMID:
14600546
13.

Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.

Singh M, Johnson L.

Clin Cancer Res. 2006 Sep 15;12(18):5312-28. Review.

14.

Animal models for colon carcinogenesis.

Pories SE, Ramchurren N, Summerhayes I, Steele G.

Arch Surg. 1993 Jun;128(6):647-53. Review.

PMID:
8503767
15.

Harnessing genetically engineered mouse models for preclinical testing.

Robles AI, Varticovski L.

Chem Biol Interact. 2008 Jan 30;171(2):159-64. Epub 2007 Feb 8. Review.

PMID:
17362899
16.

Modeling therapy resistance in genetically engineered mouse cancer models.

Rottenberg S, Jonkers J.

Drug Resist Updat. 2008 Feb-Apr;11(1-2):51-60. doi: 10.1016/j.drup.2007.11.002. Epub 2007 Dec 31. Review.

PMID:
18165147
17.

The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.

Fijneman RJ, Cormier RT.

Front Biosci. 2008 May 1;13:4144-74. Review.

PMID:
18508504
18.

Review paper: Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer.

Hynes MJ, Huang KM, Huang EH.

Vet Pathol. 2009 Sep;46(5):819-35. doi: 10.1354/vp.08-VP-0172-H-REV. Epub 2009 May 9. Review.

PMID:
19429978
19.

Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.

Rose-John S, Mitsuyama K, Matsumoto S, Thaiss WM, Scheller J.

Curr Pharm Des. 2009;15(18):2095-103. Review.

PMID:
19519447
20.

Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders.

Takao K, Yamasaki N, Miyakawa T.

Neurosci Res. 2007 Jun;58(2):124-32. Epub 2007 Feb 20. Review.

PMID:
17524507

Supplemental Content

Support Center